Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
2 Biotech Stocks to Buy and Hold for 10 Years
09:05am, Saturday, 30'th Apr 2022
These two companies have moved in opposite directions on the stock market so far this year, but now seem set to move up and to the right.
5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates
09:11am, Friday, 29'th Apr 2022
Let us take a look at some pharma/biotech stocks, REGN, BIIB, NVO, VRTX and MRNA that are poised to beat on first-quarter earnings.
5 Top Stocks for May
07:35am, Friday, 29'th Apr 2022
Looking for deals in today's market? These five stocks span many industries.
Many Big Pharma Stocks Have Outperformed. It Isn't Too Late to Buy.
03:49pm, Thursday, 28'th Apr 2022
The companies' earnings don't depend on the strength of the economy. Drug demand doesn't waver when consumers tighten their budgets.
Where Will Vertex Pharmaceuticals Be in 5 Years?
11:00am, Monday, 25'th Apr 2022
It'll almost certainly be competing in a few new markets.
3 Safe Stocks That Outperformed the S&P During the Great Recession
06:30am, Sunday, 24'th Apr 2022
These stocks are still great buys in case there's a downturn soon.
Vertex to Announce First Quarter 2022 Financial Results on May 5
04:05pm, Thursday, 21'st Apr 2022
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2022 financial results on Thursday, May 5, 2022 after the financial markets close. The company
J&J Sets in Motion Drug/Biotech Q1 Earnings: 3 Stocks to Buy
11:19am, Thursday, 21'st Apr 2022
Investors typically look at J&J's (JNJ) results to gauge how the rest of the drug sector will fare.
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Wednesday, 20'th Apr 2022
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Fantastic Biotech Stocks to Buy in April
06:04am, Monday, 18'th Apr 2022
These stocks are bright spots in an overall dismal market for biotech stocks.
3 Reasons Vertex Pharmaceuticals Is a Top Stock to Buy Now
06:18am, Saturday, 16'th Apr 2022
A research engine fueled by a $7.6 billion-per-year franchise is cranking out one hit after another.
Top 5 High-Flying Nasdaq Stocks Amid Index's YTD Meltdown
09:47am, Wednesday, 13'th Apr 2022
We have narrowed our search to five Nasdaq listed stocks that have witnessed double-digit rally year to date. These are: VRTX, SPLK, HSIC, CHKP and JKHY.
Another Nasdaq Bear Market on the Way? 3 Great Stocks to Buy Anyway
05:52am, Wednesday, 13'th Apr 2022
Bear, shmear. These stocks are great picks to buy no matter what the Nasdaq does next.
You Might Kick Yourself Later for Not Buying This Growth Stock Right Now
05:55am, Sunday, 10'th Apr 2022
This stock is really that good.
Vertex (VRTX) Stock Rallies 27% in a Year: What Lies Ahead?
09:02am, Wednesday, 06'th Apr 2022
In 2022, Vertex (VRTX) expects continued revenue growth as there are more than 25,000 patients who are addressable with Vertex's CF therapies.
